Real-World Outcomes of Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: A Large-Scale Postmarketing Surveillance in Korea

Postmarketing Surveillance ◽

Age Related ◽

2-Year Real-World Outcomes with Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: Literature Review and Meta-analysis of Patient-Relevant Outcomes

Ophthalmology and Therapy ◽

10.1007/s40123-021-00350-5 ◽

2021 ◽

Author(s):

Joao Carrasco ◽

Vincent Daien ◽

Bora M. Eldem ◽

Jelle A. Spoorendonk ◽

Jisu Yoon

Keyword(s):

Literature Review ◽

Macular Degeneration ◽

Real World ◽

Meta Analysis ◽

Age Related ◽

Twenty-four-month real-world visual outcomes of intravitreal aflibercept as monotherapy for the treatment of neovascular age-related macular degeneration

Oman Journal of Ophthalmology ◽

10.4103/ojo.ojo_24_2018 ◽

2019 ◽

Vol 12 (2) ◽

pp. 99

Author(s):

Thomas Siempis ◽

Mariam El Abiary ◽

Radhika Patel ◽

Manish Gupta

Keyword(s):

Macular Degeneration ◽

Real World ◽

Visual Outcomes ◽

Age Related ◽

Importance of continuous treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration—12-month post hoc analysis of the PERSEUS real-world evidence study

Graefe s Archive for Clinical and Experimental Ophthalmology ◽

10.1007/s00417-020-04803-8 ◽

2020 ◽

Author(s):

Joachim Wachtlin ◽

Nicole Eter ◽

Zoran Hasanbasic ◽

Georgios Keramas ◽

Christine Rech ◽

...

Keyword(s):

Macular Degeneration ◽

Real World ◽

Continuous Treatment ◽

Post Hoc Analysis ◽

Age Related ◽

Real World Evidence ◽

Intravitreal Aflibercept ◽

Post Hoc

Results of the switch from intravitreal ranibizumab to intravitreal aflibercept therapy in patients with neovascular age-related macular degeneration: A 42-month retrospective real-world study

Nigerian Journal of Clinical Practice ◽

10.4103/njcp.njcp_696_20 ◽

2021 ◽

Vol 24 (12) ◽

pp. 1824

Author(s):

E Ertan ◽

N Efe ◽

MC Sabaner ◽

M Dogan

Keyword(s):

Macular Degeneration ◽

Real World ◽

Intravitreal Ranibizumab ◽

Age Related ◽

Treat-and-extend therapy using intravitreal aflibercept for neovascular age-related macular degeneration: 2-year real-world practice data from Slovenia

BMC Ophthalmology ◽

10.1186/s12886-018-1005-x ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 2

Author(s):

Polona Jaki Mekjavić ◽

Bogdan Gregorčič ◽

Cvetka Oberč ◽

Slava Podgoršek

Keyword(s):

Macular Degeneration ◽

Real World ◽

Treat And Extend ◽

Age Related ◽

PSS3 - A SYSTEMATIC REVIEW AND META-ANALYSIS OF REAL-WORLD EVIDENCE STUDIES OF INTRAVITREAL AFLIBERCEPT IN WET AGE-RELATED MACULAR DEGENERATION

Value in Health ◽

10.1016/j.jval.2018.09.2503 ◽

2018 ◽

Vol 21 ◽

pp. S422

Author(s):

J. Yoon ◽

W. Bouwmeester ◽

L. Chuang ◽

J. Carrasco

Keyword(s):

Systematic Review ◽

Macular Degeneration ◽

Real World ◽

Meta Analysis ◽

Age Related ◽

Real World Evidence ◽

Vision-related quality of life in Japanese patients with wet age-related macular degeneration treated with intravitreal aflibercept in a real-world setting

Japanese Journal of Ophthalmology ◽

10.1007/s10384-019-00687-2 ◽

2019 ◽

Vol 63 (6) ◽

pp. 437-447 ◽

Cited By ~ 3

Author(s):

Fumi Gomi ◽

◽

Hideyuki Migita ◽

Toshiaki Sakaguchi ◽

Hiromi Okada ◽

...

Keyword(s):

Quality Of Life ◽

Macular Degeneration ◽

Real World ◽

Japanese Patients ◽

Real World Setting ◽

Age Related ◽

Intravitreal Aflibercept ◽

Related Quality

Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies

Advances in Therapy ◽

10.1007/s12325-019-01147-6 ◽

2019 ◽

Vol 37 (1) ◽

pp. 300-315 ◽

Cited By ~ 8

Author(s):

Joao Carrasco ◽

Georg-Alexander Pietsch ◽

Marie-Pierre Nicolas ◽

Cecile Koerber ◽

Craig Bennison ◽

...

Keyword(s):

Systematic Review ◽

Cost Effectiveness ◽

Macular Degeneration ◽

Real World ◽

Meta Analysis ◽

Intravitreal Ranibizumab ◽

Age Related ◽

Faculty Opinions recommendation of Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962482.793493579 ◽

2014 ◽

Author(s):

Michael Singer

Keyword(s):

Macular Degeneration ◽

Age Related ◽

Intravitreal Aflibercept ◽

Vegf Trap

Real‐world outcomes of anti‐VEGF therapy in treatment‐naïve neovascular age‐related macular degeneration diagnosed on OCT angiography: the REVEAL study

Acta Ophthalmologica ◽

10.1111/aos.15005 ◽

2021 ◽

Author(s):

Marco Lupidi ◽

Stefano Schiavon ◽

Alessio Cerquaglia ◽

Daniela Fruttini ◽

Ramkailash Gujar ◽

...

Keyword(s):

Macular Degeneration ◽

Real World ◽

Oct Angiography ◽

Anti Vegf ◽

Age Related ◽

Reveal Study ◽

Treatment Naïve